Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
17.56
+0.16 (0.92%)
At close: Jun 12, 2026, 4:00 PM EDT
17.90
+0.34 (1.94%)
After-hours: Jun 12, 2026, 4:16 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $429.09 million as of June 12, 2026. Its market cap has increased by 677.78% in one year.
Market Cap
429.09M
Enterprise Value
370.87M
1-Year Change
677.78%
Ranking
Category
Stock Price
$17.56
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $429.09M, an increase of 136.50%. That is a compound annual growth rate of 15.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 429.09M | -11.76% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 427.90M |
| Ovid Therapeutics | 425.54M |
| Contineum Therapeutics | 422.47M |
| Adlai Nortye | 418.80M |
| Prothena Corporation | 414.11M |
| Ocugen | 402.84M |
| Sagimet Biosciences | 401.39M |
| Monopar Therapeutics | 398.04M |